Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia
- Status
- COMPLETED
- Phase
- PHASE1
CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE3
Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
- Status
- TERMINATED
- Phase
- PHASE1
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS
- Status
- COMPLETED
- Phase
- PHASE1
Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL
- Status
- TERMINATED
- Phase
- N/A
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE2
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Osteonecrosis in Children With Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- N/A
Pharmacokinetic Study of Doxorubicin in Children With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)
- Status
- COMPLETED
- Phase
- N/A